Connection
John Curtin to Paclitaxel
This is a "connection" page, showing publications John Curtin has written about Paclitaxel.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.105 |
|
|
|
-
Safra T, Andreopoulou E, Levinson B, Borgato L, Pothuri B, Blank S, Tiersten A, Boyd L, Curtin J, Muggia F. Weekly paclitaxel with intermittent imatinib mesylate (Gleevec): tolerance and activity in recurrent epithelial ovarian cancer. Anticancer Res. 2010 Sep; 30(9):3243-7.
Score: 0.084
-
Blank SV, Christos P, Curtin JP, Goldman N, Runowicz CD, Sparano JA, Liebes L, Chen HX, Muggia FM. Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical reassessment. Gynecol Oncol. 2010 Dec; 119(3):451-6.
Score: 0.021